Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Mar 4, 2020

Keywords

ClinConnect Summary

This clinical trial is studying two different imaging tests, Ga-68-DOTATATE and Ga-68-DOTATOC, to see which one is better for detecting meningiomas—tumors that can occur in the membranes surrounding the brain and spinal cord. The goal is to directly compare these tests in patients who are suspected of having a meningioma and are preparing for surgery.

To participate in this trial, you must be an adult (18 years or older) who has been diagnosed with a suspected meningioma and is scheduled for surgery. Participants will need to be able to lay still on the scanner table for a certain amount of time, as discomfort or anxiety could prevent them from completing the imaging process. This trial is currently not recruiting patients yet, but it will be open to people of all genders and ages ranging from 18 to 75 years. If you meet the eligibility criteria, participating in this trial could help researchers learn more about which imaging method works best for detecting this type of tumor.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients with clinically suspected meningioma
• • Patients planned for surgery - undergoing preoperative workup
• • No contraindications to either radiotracer
• Exclusion Criteria:
• • Age less than 18 years
• • Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia.